The reduced expression of TMPRSS2 in SARS‐CoV‐infected cells hints at the potential susceptibility of tumor tissues in COVID‐19 patients with PCa to SARS‐CoV‐2 infection, which may worsen prognosis. Here, TMPRSS2 is linked to neoplasm.